Cornell — New York, New York

Cornell is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Cornell has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Mitral Valve Regurgitation (Degenerative or Functional), Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), AML.

Sponsors: Edwards Lifesciences, Millennium Pharmaceuticals, Inc., Tragara Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cornell?

Cornell has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cornell conducted?

Cornell has 6 clinical trials on record, with 3 currently active. Their work covers Mitral Valve Regurgitation (Degenerative or Functional), Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), AML.

Is Cornell accredited by Crixeo Health?

Cornell has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cornell?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.